Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
108.24
+0.63 (0.59%)
Apr 20, 2026, 4:00 PM EDT - Market closed
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $8.51 billion as of April 20, 2026. Its market cap has increased by 73.96% in one year.
Market Cap
8.51B
Enterprise Value
7.14B
1-Year Change
73.96%
Ranking
Category
Stock Price
$108.24
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $8.51B, an increase of 969.08%. That is a compound annual growth rate of 65.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 8.51B | 8.94% |
| Dec 31, 2025 | 7.81B | 40.44% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 9.83B |
| ABIVAX Société Anonyme | 9.79B |
| Axsome Therapeutics | 9.64B |
| Praxis Precision Medicines | 9.62B |
| Bio-Techne | 9.44B |
| Vaxcyte | 9.00B |
| ImmunityBio | 8.45B |
| Halozyme Therapeutics | 8.32B |